Unlock instant, AI-driven research and patent intelligence for your innovation.

Pyrimidine heterocyclic compounds, pyrimidine heterocyclic compound salts, and preparation method and application thereof

A technology of heterocyclic compounds and pyrimidines, which is applied in the field of medicinal chemistry, can solve the problems of drug resistance and curative effect reduction, and achieve the effects of low toxicity, high activity and high stability

Active Publication Date: 2017-05-31
洛阳聚慧新材料科技有限公司
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

An important factor is that the HIV virus will mutate, and long-term use of existing drugs will produce drug resistance, so that patients taking the same drug will either be ineffective or have a significantly reduced efficacy. Stability of better anti-HIV drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrimidine heterocyclic compounds, pyrimidine heterocyclic compound salts, and preparation method and application thereof
  • Pyrimidine heterocyclic compounds, pyrimidine heterocyclic compound salts, and preparation method and application thereof
  • Pyrimidine heterocyclic compounds, pyrimidine heterocyclic compound salts, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0077] The present invention also provides a method for preparing the pyrimidine heterocyclic compound of the present invention, comprising: reacting the compound of formula (II) with Rq-H to obtain the pyrimidine heterocyclic compound;

[0078]

[0079] Among them, R 1 Selected from halogen, C1-C8 alkyl, C1-C8 alkoxy, amino, acetamido or C3-C6 cycloalkyl;

[0080] R 2 Alkyl group selected from C1~C8, alkoxyl group of C1~C8, cycloalkyl group of C3~C6, amino group, amido group, cyano group, fluorine, chlorine or bromine;

[0081] The Rq is formula (Rq-1) or formula (Rq-2),

[0082]

[0083] R 3 Selected from C1~C5 alkyl, C1~C8 alkoxy or halogen; or two R 3 with R 3 A ring composed of carbon atoms where the ring is a four-membered ring, a five-membered ring or a six-membered ring

[0084] Said n is 1, 2 or 3;

[0085] R 4 selected from hydrogen or fluorine;

[0086] R 5 is selected from hydrogen, fluorine or chlorine, and R 4 and R 5 At least one is selected fr...

Embodiment 1

[0122] Intermediate 1: Synthesis of 4-((4-chloropyrimidin-2-yl)amino)benzonitrile (5)

[0123]

[0124] Step 1: Preparation of 2-chloro-4-methoxypyrimidine (2)

[0125] Dissolve 2,4-dichloropyrimidine (30g, 0.201mol) in methanol (300mL), add potassium methoxide (13g, 0.24mol) in batches at 0°C with stirring, and the reaction solution rises to room temperature, stirring overnight . Add an appropriate amount of water, extract 3 times with dichloromethane, combine the organic phases, wash with saturated brine, dry the organic phase, distill off the dichloromethane under reduced pressure to obtain a crude product, add n-hexane, stir at 0°C for 1 hour, and crystallize to obtain 16.5 g Compound 2, the yield was 57%.

[0126] The structure identification of the obtained compound is carried out, and the results are as follows: 1 H NMR (400MHz, CDCl 3 ): δ8.28(m, 1H), 6.67(m, 1H), 4.01(d, J=0.8Hz, 3H); LCMS(M+H) + : 145.0.

[0127] Step 2: Preparation of 4-((4-methoxypyrimidin...

Embodiment 2

[0146] The reaction process is as follows:

[0147]

[0148] Step 1: Preparation of ethyl 5-nitrobenzofuran-2-carboxylate (10)

[0149] Add 5-nitrosalicylaldehyde (20g, 0.119mol) and potassium carbonate (33g, 0.238mol) into a reaction flask of DMF (400mL), stir at room temperature for 1 hour, then slowly add ethyl bromoacetate (20g, 0.119mol), the temperature of the reaction solution was raised to 85°C, and the reaction was carried out for 6-7 hours, and the reaction was detected by spotting the plate until the reaction was complete. Cool to room temperature, add water and stir, a large amount of solids precipitated, suction filtered, washed with water, and dried to obtain 15g of yellow-gray solid 10, 89%.

[0150] The structure identification of the obtained compound is carried out, and the results are as follows: 1 H NMR (300MHz, CDCl 3 ): δ8.12(s, 1H), 7.87(s, 1H), 7.32(m, 2H), 4.35(q, J=7.5Hz and 14.4Hz, 2H), 1.33(m, 3H); LCMS(M +H) + : 236.1.

[0151] Step 2: Pre...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides pyrimidine heterocyclic compounds, pyrimidine heterocyclic compound salts, and a preparation method and application thereof. According to the pyrimidine heterocyclic compounds provided by the invention, specific Rq is selected, so that the obtained compounds have favorable drug resistance and long half life when being used as the medicine for treating or preventing HIV. The compounds have the advantages of high activity, low toxicity and high stability.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a pyrimidine heterocyclic compound, a pyrimidine heterocyclic compound salt, a preparation method and an application. Background technique [0002] There are two types of human immunodeficiency virus (HIV), HIV-1 and HIV-2. Patients severely infected with HIV-1 cause immunodeficiency (ARC and AIDS), which can easily lead to fatal infections. HIV is one of the most serious infectious diseases in the world. In 2012, 35 million people worldwide were infected with AIDS, 2.7 million new cases were added, and 2.3 million people died of AIDS. The latest research shows that the number of HIV infections among adolescents is on the rise, so it is still necessary to develop new drugs with high efficiency and low toxicity and new drug combinations for the treatment and prevention of AIDS. [0003] Drugs currently being developed to treat and prevent HIV are mainly to block or...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D405/12C07D413/12C07D417/12C07D471/04C07D239/48C07D239/50A61K31/506A61P31/18
CPCC07D239/48C07D239/50C07D405/12C07D413/12C07D417/12C07D471/04
Inventor 张红利杨松峰
Owner 洛阳聚慧新材料科技有限公司